Justices Deny Eli Lilly's Qui Tam Constitutional Challenge
The U.S. Supreme Court on Monday declined to review Eli Lilly's $183 million trial loss to a whistleblower who claimed the drugmaker knowingly defrauded the government by underpaying Medicaid drug rebates....To view the full article, register now.
Already a subscriber? Click here to view full article